Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease

Affiliations

• ¹ University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-net, ERN-Reconnect and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, Turin, Italy.
• ² Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
• ³ Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
• ⁴ Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
• ⁵ Department of Pathology, Sidra Medicine, Doha, Qatar.